<DOC>
	<DOC>NCT00000222</DOC>
	<brief_summary>The purpose of this study is to determine if two times a subject's daily maintenance dose will hold for 48 hours without changes in agonist and antagonist effects.</brief_summary>
	<brief_title>Alternate-Day Buprenorphine Administration. Phase II - 4</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Please contact site for information.</criteria>
	<gender>All</gender>
	<minimum_age>28 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 1993</verification_date>
</DOC>